EMD Pharmaceuticals is a subsidiary of Merck KGaA, Darmstadt, Germany. The Protein Production Laboratory (PPL), a pharmaceutical research production facility, was one of the first facilities to be constructed in a multi-phased development planned for EMD's new location. The site plan was designed to incorporate a final build-out of six buildings totaling 300,000 gross square feet: four R & D buildings, the PPL, and a commercial manufacturing facility. Ellenzweig provided master planning, a feasibility study, architectural design, and construction administration services.
The PPL is an FDA and European Union certified, small-scale manufacturing facility that produces material for testing the company's new cancer drugs in clinical trials. The PPL contains offices, laboratories, and two separate clean room production suites. The core of this plant consists of two cell-culture bioreactors, which produce the proteins from mammalian cells.
Careful consideration was given to the architectural design of the building, as it was desired that the facility blend into the campus setting of the site, yet maintain a distinctly contemporary appeal.